Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Clare P Herd, Claire L Tomlinson, Katherine Deane, Marian C Brady, Christina H Smith, Catherine M Sackley, Carl E Clarke

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)
9 Downloads (Pure)


Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.
Original languageEnglish
Pages (from-to)CD002812
JournalCochrane Database of Systematic Reviews
Publication statusPublished - 2012


  • Randomized Controlled Trials as Topic
  • Watchful Waiting
  • Parkinson Disease
  • Speech Intelligibility
  • Humans
  • Dysarthria
  • Speech Therapy
  • Language Therapy

Cite this